3.2 - Analisi di sicurezza:Saranno

3.2 - Analisi di sicurezza:
Saranno a carico della Clinica le seguenti analisi di sicurezza del prodotto cellulare da svolgere prima del congelamento e prima di ogni infusione
- Vitalità
- Immunofenotipo base (cd 34, cd 45, cd 19, cd 14, HLADR)
- Test di sterilità (aerobi, anaerobi, miceti)

Results (English) 1:

3.2-Security Analysis:Will be the responsibility of the clinic the following product safety analysis cell to play before freezing and before each infusion -Vitality Immunophenotype-base (34 cd, cd, cd, 45 19 14 cd, HLADR) -Sterility Test (aerobic, anaerobic bacteria, fungi)

Results (English) 2:

3.2 - Security analysis:
Will be borne by the clinic the following safety analysis of the cellular product to be carried out before freezing and before each infusion
- Vitality
- Immunophenotype based (cd 34 cd 45 cd 19 cd 14 HLADR)
- sterility tests (aerobic, anaerobic, fungal)

Results (English) 3:

3.2 - Safety Analysis:
will be borne by the clinic the following safety analysis of the cell product to play before freezing and before each infusion
- Vitality
- basic immunophenotype (cd 34, cd 45 and cd 19, cd 14, HLADR)
- sterility Test (aerobes, anaerobes, mycetes)